
CL
USDColgate-Palmolive Company Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$75.800
最高价
$76.585
最低价
$75.000
成交量
6.40M
公司基本面
市值
61.7B
所属行业
Household & Personal Products
国家/地区
United States
交易统计
平均成交量
5.80M
交易所
NYQ
货币
USD
52周价格范围
AI分析报告
最后更新: 2025年11月2日Colgate-Palmolive (CL): Mixed Signals Near Key Support Level
Company Overview
Colgate-Palmolive (CL), a leader in household and personal care products, operates with 34,000 employees across categories like oral hygiene, pet nutrition, and home care. Its current stock price ($76.51) sits near a 52-week low ($74.62), with a market cap of $62.3B and a P/E ratio of 19.96. The company recently cut its annual sales forecast, citing weak consumer demand, after reporting Q3 revenue growth of 1.9%--below analyst expectations.
Price Action Review
Over the past three months:
- Trend: Bearish. Shares dropped 10.8% from $85.78 (Aug 20) to $76.51 (Oct 31).
- Volatility: Low (avg volume: 5.7M shares), though sudden sell-offs occurred in late October (e.g., $79.86 → $77.14 in 3 days).
- Key Levels:
- Support: $76.37 (Bollinger Band lower bound).
- Resistance: $85.43 (Oct 20 high) and $88.84 (analyst price target).
Technical indicators suggest a bullish breakout is possible if prices hold above $74.95 (stop-loss level). The MACD golden cross and surging On-Balance Volume (15.4x average) hint at short-term buying pressure.
News Sentiment Analysis
Recent headlines show conflicting signals:
- Negative: CL lowered its annual sales forecast on Oct 31, citing "rising economic uncertainty" impacting demand for premium-priced products--even in essentials like toothpaste.
- Neutral: Q3 organic sales rose just 0.4%, dragged down by a "non-strategic exit from private-label pet sales."
- Positive: JP Morgan reiterated an "Overweight" rating on Oct 10, though cutting its price target from $95 to $88.
Analyst sentiment remains optimistic
相关新闻
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive with a Equal-Weight and lowers the price target from $82 to $80.
Procter & Gamble can be sued over Kid's Crest packaging, US judge rules
Procter & Gamble must face a lawsuit alleging that its packaging for Kid's Crest suggests that children can use more of the toothpaste than is safe.
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
UBS analyst Peter Grom maintains Colgate-Palmolive with a Buy and lowers the price target from $92 to $90.
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
Citigroup analyst Filippo Falorni maintains Colgate-Palmolive with a Buy and lowers the price target from $105 to $95.
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive with a Overweight and lowers the price target from $96 to $87.
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive with a Overweight and lowers the price target from $88 to $87.
Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94
Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive with a Outperform and lowers the price target from $100 to $94.
AI预测Beta
AI建议
更新于: 2025年11月5日 07:26
64.8% 置信度
风险与交易
入场点
$76.25
止盈点
$78.60
止损点
$74.86
关键因素
相关股票
DDC
DDC Enterprise Limited Ordinary Shares
PNC
PNC Financial Services
PEG
Public Service Enterprise Group
MSC
Studio City International Holdings Limited American depositary shares each representing four ordinary shares
CDLR
Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)
保持更新
设置价格提醒,获取AI分析更新和实时市场新闻。